Clinical Evidence in the Matrixyl vs GHK-Cu Comparison Evaluating the clinical evidence in the Matrixyl vs GHK-Cu literature requires distinguishing between cosmetic clinical trials (which evaluate consumer-visible outcomes like wrinkle depth) and biomarker-based research studies (which measure gene expression, protein synthesis, and cellular function)
Supplied in Australia by StrongPep Labs for research use only
Research Notes Demonstrates accelerated wound closure, enhanced collagen deposition, improved muscle and nerve regeneration in animal models
The expression of various genes encoding complex I-driving proteins, such as NDUFC1, NDUFB4, NDUFB10, NDUFB11, NDUFA12, NDUFA13, NDUFS7, NDUFS2, and NDUFA7 , showed the most pronounced reduction in IC-B cells in ABMR ( Figure 4D )